poisar

Stocks · News reference

8-K filing — enGene Therapeutics Inc. (ENGNW)

Jul 17, 2026, 8:05 PMSEC EDGAR

Filed: 2026-07-17 AccNo: 0001193125-26-307795 Size: 16 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Read original sourceMore stocks news

Reference details

Connected markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ENGNW
Source
edgar
Observed
Jul 17, 2026, 8:05 PM
Checked
Jul 17, 2026, 8:05 PM
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Jun 18, 2026, 8:06 PMSEC EDGAR

    8-K/A filing — enGene Therapeutics Inc. (ENGNW)

    Filed: 2026-06-18 AccNo: 0001193125-26-275815 Size: 202 KB Item 2.05: Cost Associated with Exit or Disposal Activities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

    Read original at edgar
    ENGNW